Bramanti Alessia, Corallo Angelo, Clemente Gennaro, Greco Luca, Garofano Marina, Giordano Massimo, Pascarelli Claudio, Mitrano Gianvito, Di Palo Maria Pia, Di Spirito Federica, Amato Massimo, Bartolomeo Marianna, Del Sorbo Rosaria, Ciccarelli Michele, Bramanti Placido, Ritrovato Pierluigi
Department of Medicine, Surgery and Dentistry, University of Salerno, Via S. Allende, 84081 Baronissi, Italy.
Department of Engineering for Innovation, University of Salento, 73100 Lecce, Italy.
Healthcare (Basel). 2025 Feb 27;13(5):517. doi: 10.3390/healthcare13050517.
Non-communicable diseases (NCDs) represent a leading cause of global mortality, demanding innovative approaches to management. Voice assistants (VAs) have emerged as promising tools in healthcare, offering support for self-management, behavioral engagement, and patient care. This systematic review evaluates the role of VAs in NCD management, analyzing their impact on clinical and behavioral outcomes, quality of life, usability, and user experiences while identifying barriers to their adoption.
A systematic search was conducted in PubMed, Scopus, and Web of Science from January 2014 to October 2024. Studies were selected based on predefined inclusion and exclusion criteria using the PRISMA guidelines. Data extraction focused on outcomes such as usability, acceptability, adherence, clinical metrics, and quality of life. The risk of bias was assessed using the Cochrane Risk of Bias (RoB) 2 and ROBINS-I tools.
Eight studies involving 541 participants were included, examining VAs across various NCD contexts such as diabetes, cardiovascular diseases, and mental health. While VAs demonstrated good usability and moderate adherence, their clinical and quality-of-life outcomes were modest. Behavioral improvements, such as increased physical activity and problem-solving skills, were noted in some interventions. Key challenges included privacy concerns, speech recognition errors, and accessibility issues.
VAs show potential as supportive tools in NCD management, especially for enhancing patient engagement and self-management, and their impact on clinical outcomes and long-term usability requires further investigation. Future research should focus on diverse populations, standardized metrics, and comparative studies with alternative technologies.
非传染性疾病是全球死亡的主要原因,需要创新的管理方法。语音助手已成为医疗保健领域有前景的工具,为自我管理、行为参与和患者护理提供支持。本系统评价评估了语音助手在非传染性疾病管理中的作用,分析了它们对临床和行为结果、生活质量、可用性和用户体验的影响,同时确定了其采用的障碍。
2014年1月至2024年10月在PubMed、Scopus和Web of Science中进行了系统检索。根据预先定义的纳入和排除标准,使用PRISMA指南选择研究。数据提取集中在可用性、可接受性、依从性、临床指标和生活质量等结果上。使用Cochrane偏倚风险(RoB)2和ROBINS-I工具评估偏倚风险。
纳入了八项涉及541名参与者的研究,研究了语音助手在糖尿病、心血管疾病和心理健康等各种非传染性疾病背景下的应用。虽然语音助手表现出良好的可用性和中等的依从性,但其临床和生活质量结果并不显著。在一些干预措施中,观察到了行为改善,如身体活动增加和解决问题的能力提高。主要挑战包括隐私问题、语音识别错误和可及性问题。
语音助手在非传染性疾病管理中显示出作为支持工具的潜力,特别是在增强患者参与度和自我管理方面,其对临床结果和长期可用性的影响需要进一步研究。未来的研究应关注不同人群、标准化指标以及与替代技术的比较研究。